OCC 5.84% 64.5¢ orthocell limited

All eyes have been on the Ortho-ATI whilst FDA and TGA is...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 2,383 Posts.
    lightbulb Created with Sketch. 345
    All eyes have been on the Ortho-ATI whilst FDA and TGA is ticking along for Nerve that will be first to market, we are almost overdue TGA updates and IND FDA update must be extremely close.

    I feel Nerve will be the biggest news on the horizon most likely January, disappointing market reaction to fantastic Ortho-Ati results.

    Could be all those 25 cents options selling some stock to convert the balance as they expire Dec 31st but mostly already converted.
 
watchlist Created with Sketch. Add OCC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.